Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


12.06.2017

18 Br J Dermatol
2 Cancer
9 Clin Exp Dermatol
10 Cutis
1 Int J Cancer
1 Int J Dermatol
3 J Cutan Pathol
1 J Dermatol
8 J Invest Dermatol
4 Lancet
11 Lancet Oncol
2 N Engl J Med
3 Plast Reconstr Surg
1 PLoS Genet
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Dermatol

  1. BISSONNETTE R, Luger T, Thaci D, Toth D, et al
    Secukinumab Sustains Good Efficacy and Favourable Safety in Moderate to Severe Psoriasis up to 3 Years of Treatment: Results from A Double-Blind Extension Study.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15706.
    PubMed     Text format     Abstract available

  2. BALATO A, Caiazzo G
    Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis.
    Br J Dermatol. 2017;176:1437-1438.
    PubMed     Text format    

  3. DRUCKER AM
    Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?
    Br J Dermatol. 2017;176:1441-1442.
    PubMed     Text format    

  4. CERIO R, Moir G
    Palliative electrochemotherapy treatment of metastatic malignant melanoma.
    Br J Dermatol. 2017;176:1427.
    PubMed     Text format    

  5. JONES G
    Methotrexate increases the risk of melanoma: or does it?
    Br J Dermatol. 2017;176:1429-1430.
    PubMed     Text format    

  6. TRAUPE H
    Psoriasis and the interleukin-10 family: evidence for a protective genetic effect, but not an easy target as a drug.
    Br J Dermatol. 2017;176:1438-1439.
    PubMed     Text format    

  7. AGNER T
    Biomarkers in contact dermatitis.
    Br J Dermatol. 2017;176:1434-1435.
    PubMed     Text format    

  8. MOSCARELLA E, Ametrano O, Diplomatico M, De Chiara C, et al
    Image Gallery: Kaposiform haemangioendothelioma.
    Br J Dermatol. 2017;176:e124.
    PubMed     Text format    

  9. HOFFMANN JHO, Knoop C, Enk AH, Hadaschik EN, et al
    Long persistence of TNF-alpha antagonist induced autoantibodies under subsequent treatment with Ustekinumab but no adverse effects: a case study of 14 psoriasis patients.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15701.
    PubMed     Text format     Abstract available

  10. BONNEKOH H, Scheffel J, Maurer M, Krause K, et al
    The use of skin biomarker profiles to distinguish Schnitzler's syndrome from chronic spontaneous urticaria: results of a pilot study.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15705.
    PubMed     Text format     Abstract available

  11. STICHERLING M, Mrowietz U, Augustin M, Thaci D, et al
    Secukinumab is Superior to Fumaric Acid Esters in Treating Subjects with Moderate to Severe Plaque Psoriasis who are Naive to Systemic Treatments: Results from the Randomized Controlled PRIME Trial.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15707.
    PubMed     Text format     Abstract available

  12. DI FUSCO D, Laudisi F, Dinallo V, Monteleone I, et al
    Smad7 positively regulates keratinocyte proliferation in psoriasis.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15703.
    PubMed     Text format     Abstract available

  13. KIESELOVA K, Santiago F, Henrique M, Cunha F, et al
    Image Gallery: Cutaneous lesions in the external auditory canal causing hearing loss.
    Br J Dermatol. 2017;176:e119.
    PubMed     Text format    

  14. EGU DT, Walter E, Spindler V, Waschke J, et al
    Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis.
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15721.
    PubMed     Text format     Abstract available

  15. PAPP KA, Bachelez H, Blauvelt A, Winthrop KL, et al
    Infections from 7 Clinical Trials of Ixekizumab, an Anti-Interleukin-17A Monoclonal Antibody, in Patients with Moderate-to-Severe Psoriasis.
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15723.
    PubMed     Text format     Abstract available

  16. BLAUVELT A, Ferris LK, Yamauchi PS, Qureshi A, et al
    Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a Phase 3b, randomized, double-blinded, active-controlled, multicenter study (PSTELLAR).
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15722.
    PubMed     Text format     Abstract available

  17. PAMPALAKIS G, Sotiropoulou G
    Insights into the regulation of proteolytic pathways in skin differentiation.
    Br J Dermatol. 2017;176:1433-1434.
    PubMed     Text format    

  18. LEE WJ, Kim YJ, Lee YJ, Won CH, et al
    VEGF protein expression is associated with a poor prognosis in cutaneous extranodal NK/T-cell lymphoma patients.
    Br J Dermatol. 2017 Jun 9. doi: 10.1111/bjd.15720.
    PubMed     Text format     Abstract available


    Cancer

  19. NYANTE SJ, Lee SS, Benefield TS, Hoots TN, et al
    The association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohort.
    Cancer. 2016 Sep 28. doi: 10.1002/cncr.30281.
    PubMed     Text format     Abstract available

  20. SILVESTRI V, Zelli V, Valentini V, Rizzolo P, et al
    Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
    Cancer. 2017;123:210-218.
    PubMed     Text format     Abstract available


    Clin Exp Dermatol

  21. BRAMBILLA L, Esposito L, Nazzaro G, Tourlaki A, et al
    Onset of Kaposi sarcoma and Merkel cell carcinoma during low-dose steroid therapy for rheumatic polymyalgia.
    Clin Exp Dermatol. 2017 Jun 9. doi: 10.1111/ced.13151.
    PubMed     Text format    

  22. PAGLIARELLO C, Scrivani S, Fabrizi G, Feliciani C, et al
    An under-recognized, life-threatening complication of atopic dermatitis.
    Clin Exp Dermatol. 2017 Jun 9. doi: 10.1111/ced.13171.
    PubMed     Text format    

  23. CHANG X, Zhu W, Zhang H, Lian S, et al
    Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
    Clin Exp Dermatol. 2017 Jun 9. doi: 10.1111/ced.13119.
    PubMed     Text format     Abstract available

  24. CHEN T, Zhang LW, Fu LX, Wu YB, et al
    Systemic ALA-PDT effectively blocks the development of psoriasis-like lesions and alleviates leucocyte infiltration in the K14-VEGF transgenic mouse.
    Clin Exp Dermatol. 2017 Jun 9. doi: 10.1111/ced.13148.
    PubMed     Text format     Abstract available

  25. VAN DER LEE M, Arabkhazaeli A, van Erp FC, Raaijmakers JA, et al
    Atopic dermatitis characteristics and medication-use patterns in school-age children with AD and asthma symptoms.
    Clin Exp Dermatol. 2017 Jun 6. doi: 10.1111/ced.13111.
    PubMed     Text format     Abstract available

  26. KHULLAR G, De D, Narang T, Saikia UN, et al
    Pigmented macular variant of chronic cutaneous lupus erythematosus: an under-recognized subset in dark skin.
    Clin Exp Dermatol. 2017 Jun 7. doi: 10.1111/ced.13160.
    PubMed     Text format    

  27. SHAH M
    Clinical outcomes in a specialist male genital skin clinic: prospective follow-up of 600 patients.
    Clin Exp Dermatol. 2017 Jun 8. doi: 10.1111/ced.13144.
    PubMed     Text format     Abstract available

  28. WOO WA, Mitchell CD, Wakefield E, Hextall J, et al
    The importance of full skin examination in diagnosing cutaneous melanoma.
    Clin Exp Dermatol. 2017 Jun 7. doi: 10.1111/ced.13155.
    PubMed     Text format    

  29. KUSAJIMA E, Furukawa H, Funayama E, Oyama A, et al
    Vesiculobullous melanoma: an unusual manifestation of in-transit metastasis.
    Clin Exp Dermatol. 2017 Jun 7. doi: 10.1111/ced.13156.
    PubMed     Text format     Abstract available


    Cutis

  30. AMOURI M, Mesrati H, Chaaben H, Masmoudi A, et al
    Congenital hemangioma.
    Cutis. 2017;99:E31-E33.
    PubMed     Text format     Abstract available

  31. MUGLIA C, Bronsnick T, Kirkorian AY, Cha J, et al
    Questioning the specificity and sensitivity of ELISA for bullous pemphigoid diagnosis.
    Cutis. 2017;99:E27-E30.
    PubMed     Text format     Abstract available

  32. ELSTON DM
    Clinicians should retain the ability to choose a pathologist.
    Cutis. 2017;99:12-13.
    PubMed     Text format    

  33. TJARKS BJ, Ferringer TC
    Red-blue nodule on the scalp.
    Cutis. 2017;99:15.
    PubMed     Text format    

  34. SALGADO F, Handler MZ, Schwartz RA
    Shedding light on onychomadesis.
    Cutis. 2017;99:33-36.
    PubMed     Text format     Abstract available

  35. HIBLER BP, Rossi AM, DeLeo VA
    Bilateral symmetric onycholysis of distal fingernails.
    Cutis. 2017;99:E8-E11.
    PubMed     Text format    

  36. CH'NG CC, Wong SM, Lee YY
    Painful oral and genital ulcers.
    Cutis. 2017;99:E1-E3.
    PubMed     Text format    

  37. ROCHA VB, Moraes RA, Pereira LB
    Cardiofaciocutaneous syndrome and the dermatologist's contribution to diagnosis.
    Cutis. 2017;99:E4-E7.
    PubMed     Text format    

  38. KINDLE S, Fanciullo J
    Healing of leg ulcers associated with granulomatosis with polyangiitis (Wegener granulomatosis) after rituximab therapy.
    Cutis. 2017;99:E12-E15.
    PubMed     Text format    

  39. WALKER A, Favreau T
    Localized pemphigus foliaceus.
    Cutis. 2017;99:E23-E26.
    PubMed     Text format    


    Int J Cancer

  40. LAURENZANA A, Chilla A, Luciani C, Peppicelli S, et al
    uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30817.
    PubMed     Text format     Abstract available


    Int J Dermatol

  41. DE FREITAS RS, Neves PS, Charbel CE, Criado PR, et al
    Investigation of superficial mycosis in cutaneous allergy patients using topical or systemic corticosteroids.
    Int J Dermatol. 2017 Jun 8. doi: 10.1111/ijd.13651.
    PubMed     Text format    


    J Cutan Pathol

  42. KHULLAR G, De D, Saikia UN, Handa S, et al
    An unusual case of idiopathic localized giant cell lichenoid dermatitis.
    J Cutan Pathol. 2017 Jun 7. doi: 10.1111/cup.12960.
    PubMed     Text format    

  43. CHEN TY, Morrison AO, Cockerell CJ
    Cutaneous Malignancies Simulating Seborrheic Keratoses: An Underappreciated Phenomenon?
    J Cutan Pathol. 2017 Jun 7. doi: 10.1111/cup.12975.
    PubMed     Text format     Abstract available

  44. GOTO K
    Similarity between non-neural granular cell tumors and granular cell fibrous papules.
    J Cutan Pathol. 2017 Jun 8. doi: 10.1111/cup.12974.
    PubMed     Text format    


    J Dermatol

  45. FUKUMOTO T, Nishiumi S, Fujiwara S, Yoshida M, et al
    Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
    J Dermatol. 2017 Jun 8. doi: 10.1111/1346-8138.13921.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  46. MARUKIAN NV, Deng Y, Gan G, Ren I, et al
    Establishing and Validating an Ichthyosis Severity Index.
    J Invest Dermatol. 2017 Jun 5. pii: S0022-202X(17)31554.
    PubMed     Text format     Abstract available

  47. BOTCHKAREV VA
    Second International Symposium-Epigenetic Regulation of Skin Regeneration and Aging: From Chromatin Biology towards the Understanding of Epigenetic Basis of Skin Diseases.
    J Invest Dermatol. 2017 Jun 2. pii: S0022-202X(17)31401.
    PubMed     Text format    

  48. SMITH SH, Jayawickreme C, Rickard DJ, Nicodeme E, et al
    Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.
    J Invest Dermatol. 2017 Jun 5. pii: S0022-202X(17)31543.
    PubMed     Text format     Abstract available

  49. XUE J, Yu C, Sheng W, Zhu W, et al
    The Nrf2/GCH1/BH4 axis ameliorates radiation-induced skin injury by modulating the ROS cascade.
    J Invest Dermatol. 2017 Jun 5. pii: S0022-202X(17)31604.
    PubMed     Text format     Abstract available

  50. HERMANN H, Runnel T, Aab A, Baurecht H, et al
    miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis.
    J Invest Dermatol. 2017 Jun 5. pii: S0022-202X(17)31551.
    PubMed     Text format     Abstract available

  51. YANG L, Fan X, Cui T, Dang E, et al
    Nrf2 promotes keratinocyte proliferation in psoriasis through up-regulation of Keratin 6, Keratin 16 and Keratin 17.
    J Invest Dermatol. 2017 May 30. pii: S0022-202X(17)31561.
    PubMed     Text format     Abstract available

  52. NEMETH T, Virtic O, Sitaru C, Mocsai A, et al
    The Syk tyrosine kinase is required for skin inflammation in an in vivo mouse model of epidermolysis bullosa acquisita.
    J Invest Dermatol. 2017 May 30. pii: S0022-202X(17)31563.
    PubMed     Text format     Abstract available

  53. THEODOSAKIS N, Micevic G, Langdon CG, Ventura A, et al
    p90RSK blockade inhibits dual BRAF and MEK inhibitor-resistant melanoma by targeting protein synthesis.
    J Invest Dermatol. 2017 Jun 6. pii: S0022-202X(17)31603.
    PubMed     Text format     Abstract available


    Lancet

  54. PRINCE HM, Kim YH, Horwitz SM, Dummer R, et al
    Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
    Lancet. 2017 Jun 6. pii: S0140-6736(17)31266.
    PubMed     Text format     Abstract available

  55. PORCU P, Sahu J
    A positive randomised trial in cutaneous T-cell lymphoma.
    Lancet. 2017 Jun 6. pii: S0140-6736(17)31473.
    PubMed     Text format    

  56. REICH K, Papp KA, Blauvelt A, Tyring SK, et al
    Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
    Lancet. 2017 Jun 5. pii: S0140-6736(17)31279.
    PubMed     Text format     Abstract available

  57. BACHELEZ H
    Interleukin 23 inhibitors for psoriasis: not just another number.
    Lancet. 2017 Jun 5. pii: S0140-6736(17)31474.
    PubMed     Text format    


    Lancet Oncol

  58. BERSANELLI M, Leonetti A, Buti S, Michiara M, et al
    "Finding NEMO" in NRAS-mutant melanoma: a step towards a sequential strategy?
    Lancet Oncol. 2017;18:e298.
    PubMed     Text format    

  59. LLOMBART-CUSSAC A, Cortes J, Pare L, Galvan P, et al
    HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
    Lancet Oncol. 2017 Feb 23. pii: S1470-2045(17)30021.
    PubMed     Text format     Abstract available

  60. ZHANG P, Sun T, Zhang Q, Yuan Z, et al
    Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.
    Lancet Oncol. 2017 Feb 10. pii: S1470-2045(17)30088.
    PubMed     Text format     Abstract available

  61. POLGAR C, Ott OJ, Hildebrandt G, Kauer-Dorner D, et al
    Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year r
    Lancet Oncol. 2017;18:259-268.
    PubMed     Text format     Abstract available

  62. DIKMANS RE, Negenborn VL, Bouman MB, Winters HA, et al
    Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial.
    Lancet Oncol. 2017;18:251-258.
    PubMed     Text format     Abstract available

  63. WALLINGTON M, Saxon EB, Bomb M, Smittenaar R, et al
    30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
    Lancet Oncol. 2016;17:1203-16.
    PubMed     Text format     Abstract available

  64. ZIELINSKI C, Lang I, Inbar M, Kahan Z, et al
    Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
    Lancet Oncol. 2016 Aug 5. pii: S1470-2045(16)30154.
    PubMed     Text format     Abstract available

  65. SAUVAGET C, Nishino Y, Konno R, Tase T, et al
    Challenges in breast and cervical cancer control in Japan.
    Lancet Oncol. 2016;17:e305-12.
    PubMed     Text format     Abstract available

  66. GHISLAIN I, Zikos E, Coens C, Quinten C, et al
    Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials.
    Lancet Oncol. 2016;17:e294-304.
    PubMed     Text format     Abstract available

  67. DAVIES MA, Saiag P, Robert C, Grob JJ, et al
    Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
    Lancet Oncol. 2017 Jun 2. pii: S1470-2045(17)30429.
    PubMed     Text format     Abstract available

  68. FOUAD TM, Barrera AM, Reuben JM, Lucci A, et al
    Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.
    Lancet Oncol. 2017;18:e228-e232.
    PubMed     Text format     Abstract available


    N Engl J Med

  69. COIT D
    The Enigma of Regional Lymph Nodes in Melanoma.
    N Engl J Med. 2017;376:2280-2281.
    PubMed     Text format    

  70. FARIES MB, Thompson JF, Cochran AJ, Andtbacka RH, et al
    Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
    N Engl J Med. 2017;376:2211-2222.
    PubMed     Text format     Abstract available


    Plast Reconstr Surg

  71. MYCKATYN TM, Wagner IJ, Mehrara BJ, Crosby MA, et al
    Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study.
    Plast Reconstr Surg. 2017;139:11-18.
    PubMed     Text format     Abstract available

  72. KOMOROWSKA-TIMEK E, Turfe Z, Davis AT
    Outcomes of Prosthetic Reconstruction of Irradiated and Nonirradiated Breasts with Fat Grafting.
    Plast Reconstr Surg. 2017;139:1e-9e.
    PubMed     Text format     Abstract available

  73. FREY JD, Choi M, Karp NS
    The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Healing after Nipple-Sparing Mastectomy.
    Plast Reconstr Surg. 2017;139:10e-19e.
    PubMed     Text format     Abstract available


    PLoS Genet

  74. STRICKER TP, Brown CD, Bandlamudi C, McNerney M, et al
    Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
    PLoS Genet. 2017;13:e1006589.
    PubMed     Text format     Abstract available


    PLoS One

  75. MENEGUZZI VC, Santos CB, Leite GR, Fux B, et al
    Environmental Niche Modelling of Phlebotomine Sand Flies and Cutaneous Leishmaniasis Identifies Lutzomyia intermedia as the Main Vector Species in Southeastern Brazil.
    PLoS One. 2016;11:e0164580.
    PubMed     Text format     Abstract available

  76. LAWRENCE CL, Baldwin AS
    Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0165005.
    PubMed     Text format     Abstract available

  77. HREBIEN S, O'Leary B, Beaney M, Schiavon G, et al
    Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
    PLoS One. 2016;11:e0165023.
    PubMed     Text format     Abstract available

  78. FU J, Wu L, Jiang M, Li D, et al
    Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
    PLoS One. 2016;11:e0164921.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: